Source: Eur Respir J, 55 (4) 2000447; 10.1183/13993003.00447-2020
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Daisy Duan, Chenjuan Gu, Jonathan C. Jun. Altered metabolism in pulmonary hypertension: fuelling the fire or just smoke?. Eur Respir J, 55 (4) 2000447; 10.1183/13993003.00447-2020

Member's Comments

No comment yet.

Related content which might interest you: Inflammation in pulmonary arterial hypertension: is it time to quell the fire? Source: Eur Respir J 2014; 43: 685-688 Year: 2014 Effects of cigarette smoke and hypoxia on pulmonary circulation in the guinea pig Source: Eur Respir J 2011; 38: 617-627 Year: 2011 Inflammation in chronic thromboembolic pulmonary hypertension: accomplice or bystander in altered angiogenesis? Source: Eur Respir J 2015; 46: 303-306 Year: 2015 Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension Source: Eur Respir Rev, 30 (162) 210161; 10.1183/16000617.0161-2021 Year: 2021 Metabolic dysfunction associated with redox imbalance in pulmonary hypertension: Effects of the prolonged sildenafil use Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Tobacco smoke: A risk factor for pulmonary arterial hypertension? A case control study Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Pulmonary hypertension in chronic obstructive pulmonary disease: the role of cigarette smoking Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006 Pulmonary hypertension and chronic lung disease: where are we headed? Source: Eur Respir Rev, 28 (153) 190065; 10.1183/16000617.0065-2019 Year: 2019 Beyond personal smoking: does environmental tobacco smoke cause chronic obstructive pulmonary disease? Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease Year: 2005 How does inflammation contribute to pulmonary hypertension? Source: Eur Respir J, 51 (1) 1702403; 10.1183/13993003.02403-2017 Year: 2018 Tobacco smoke in patients with pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Olfactory receptors in pulmonary arterial hypertension: A novel pathway of vascular remodeling? Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Iron deficiency in pulmonary arterial hypertension: A matter of definition! Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Reprogramming of cellular metabolism: driver for airway remodelling in COPD? Source: Eur Respir J, 50 (5) 1702197; 10.1183/13993003.02197-2017 Year: 2017 Cadmium in tobacco smokers: a neglected link to lung disease? Source: Eur Respir Rev, 27 (147) 170122; 10.1183/16000617.0122-2017 Year: 2018 Atrial fibrillation in the course of pulmonary embolism: just a little smoke or fuel to the fire? Source: Virtual Congress 2020 – Cardiovascular morbidity and mortality after pulmonary embolism Year: 2020 A crossroads between the heart and lungs: air pollution and pulmonary hypertension Source: Eur Respir J, 53 (5) 1900654; 10.1183/13993003.00654-2019 Year: 2019 Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis? Source: Eur Respir J 2010; 35: 730-734 Year: 2010 Pulmonary hypertension at exercise in COPD: does it matter? Source: Eur Respir J 2013; 41: 1002-1004 Year: 2013 Sex differences in pulmonary hypertension: are we cleaning up the mess? Source: Eur Respir J 2016; 47: 390-393 Year: 2016